A carregar...
Proteomic risk markers for coronary heart disease and stroke: validation and mediation of randomized trial hormone therapy effects on these diseases
BACKGROUND: We previously reported mass spectrometry-based proteomic discovery research to identify novel plasma proteins related to the risk of coronary heart disease (CHD) and stroke, and to identify proteins with concentrations affected by the use of postmenopausal hormone therapy. Here we report...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3971342/ https://ncbi.nlm.nih.gov/pubmed/24373343 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/gm517 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|